However, it was proposed that LGALS3BP is associated with a favorable clinical outcome in colorectal carcinoma [68–80], pleural mesothelioma [81] and Ewing’s sarcoma [82]. This evidence concerns the gene LGALS3BP and colorectal carcinoma.